Literature DB >> 3985125

Mediators of lung injury in mice following systemic activation of complement.

H W Tvedten, G O Till, P A Ward.   

Abstract

Acute lung injury has been produced in mice by the intravenous injection of cobra venom factor. The marked attenuation of lung injury in C5-deficient mice indicates an absolute requirement for C5 in the development of lung injury. Similar studies carried out in beige mice suggest that leukocytic proteinases play, at best, a limited role in the injury. Neutrophil or platelet depletion resulted in a marked reduction in the extent of lung injury, suggesting that both platelets as well as neutrophils contribute to the injury. Treatment of mice with catalase provided a marked degree of protection from the lung injury, while treatment with superoxide dismutase produced limited protection, which suggests that H2O2 or its derivatives are involved in the induction of acute lung injury. By the use of transmission electron microscopy, areas of lung vascular injury, as manifested by extensive blebbing of endothelial cells, were associated with intravascular aggregates of platelets, neutrophils, and fibrin. Finally, lipoxygenase and thromboxane synthetase inhibitors afforded some protection against cobra venom factor-induced acute lung injury, while cyclooxygenase inhibitors gave variable results. These data suggest that acute lung injury in mice following systemic activation of complement has an absolute requirement for C5, is dependent on a role of both neutrophils as well as platelets, and can be linked to the generation of toxic oxygen products by neutrophils.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985125      PMCID: PMC1888073     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Pulmonary microvascular alterations and injury induced by complement fragments: synergistic effect of complement activation, neutrophil sequestration, and prostaglandins.

Authors:  P M Henson; G L Larsen; R O Webster; B C Mitchell; A J Goins; J E Henson
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

3.  Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions.

Authors:  P Needleman; B Bryan; A Wyche; S D Bronson; K Eakins; J A Ferrendelli; M Minkes
Journal:  Prostaglandins       Date:  1977-11

4.  Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.

Authors:  G O Till; K J Johnson; R Kunkel; P A Ward
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

5.  Immunologic vasculitis in beige mice with deficiency of leukocytic neutral protease.

Authors:  K J Johnson; J Varani; J Oliver; P A Ward
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

6.  Production of acute pulmonary injury by leukocytes and activated complement.

Authors:  D C Hohn; A J Meyers; S T Gherini; A Beckmann; R E Markison; A M Churg
Journal:  Surgery       Date:  1980-07       Impact factor: 3.982

7.  Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment.

Authors:  J M Harlan; P D Killen; L A Harker; G E Striker; D G Wright
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

8.  Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.

Authors:  A J Marcus; B B Weksler; E A Jaffe; M J Broekman
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness.

Authors:  P J Spagnuolo; J J Ellner; A Hassid; M J Dunn
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice.

Authors:  J D Vassalli; A Granelli-Piperno; C Griscelli; E Reich
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  25 in total

1.  Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis.

Authors:  I J Messias-Reason; S Y Hayashi; R M Nisihara; M Kirschfink
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

Review 2.  Amicus or adversary: platelets in lung biology, acute injury, and inflammation.

Authors:  Fernando A Bozza; Amrapali M Shah; Andrew S Weyrich; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

3.  Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.

Authors:  Christine T N Pham; Lynne M Mitchell; Jennifer L Huang; Christopher M Lubniewski; Otto F Schall; J Kendall Killgore; Dipanjan Pan; Samuel A Wickline; Gregory M Lanza; Dennis E Hourcade
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 4.  Vascular occlusion of the retina: an experimental model. I. Leukocyte aggregates.

Authors:  G Scheurer; G Praetorius; B Damerau; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

5.  Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome.

Authors:  G Zilow; J A Sturm; U Rother; M Kirschfink
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

Review 7.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

Review 8.  Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

9.  Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase.

Authors:  H Kubo; D Morgenstern; W M Quinian; P A Ward; M C Dinauer; C M Doerschuk
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine.

Authors:  P Renesto; V Balloy; B B Vargaftig; M Chignard
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.